These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27603163)

  • 1. A randomized, placebo-controlled pilot trial of N-acetylcysteine on oxidative stress and endothelial function in HIV-infected older adults receiving antiretroviral treatment.
    Gupta SK; Kamendulis LM; Clauss MA; Liu Z
    AIDS; 2016 Sep; 30(15):2389-91. PubMed ID: 27603163
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of N-acetylcysteine(NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial.
    Akerlund B; Jarstrand C; Lindeke B; Sönnerborg A; Akerblad AC; Rasool O
    Eur J Clin Pharmacol; 1996; 50(6):457-61. PubMed ID: 8858271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).
    Diaz-Sandoval LJ; Kosowsky BD; Losordo DW
    Am J Cardiol; 2002 Feb; 89(3):356-8. PubMed ID: 11809444
    [No Abstract]   [Full Text] [Related]  

  • 5. N-acetylcysteine reduces malondialdehyde levels in chronic hemodialysis patients--a pilot study.
    Trimarchi H; Mongitore MR; Baglioni P; Forrester M; Freixas EA; Schropp M; Pereyra H; Alonso M
    Clin Nephrol; 2003 Jun; 59(6):441-6. PubMed ID: 12834176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of N-acetylcysteine on endothelial function, B-type natriuretic peptide and renal function in patients with the cardiorenal syndrome: a pilot cross over randomised controlled trial.
    Camuglia AC; Maeder MT; Starr J; Farrington C; Kaye DM
    Heart Lung Circ; 2013 Apr; 22(4):256-9. PubMed ID: 23219310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of N-acetylcysteine on cardiac injury and oxidative stress after abdominal aortic aneurysm repair: a randomized controlled trial.
    Mahmoud KM; Ammar AS
    Acta Anaesthesiol Scand; 2011 Sep; 55(8):1015-21. PubMed ID: 22092168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidaemic, normotensive, patients with non-insulin-dependent diabetes.
    De Mattia G; Bravi MC; Laurenti O; Cassone-Faldetta M; Proietti A; De Luca O; Armiento A; Ferri C
    Diabetologia; 1998 Nov; 41(11):1392-6. PubMed ID: 9833950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of N-acetyl cysteine on oxidative stress among patients with pre-eclampsia.
    Motawei SM; Attalla SM; Gouda HE; Harouny MA; Elmansoury AM
    Int J Gynaecol Obstet; 2016 Nov; 135(2):226-227. PubMed ID: 27692686
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of administration of oral N-acetylcysteine to reduce oxidative stress in chronic hemodialysis patients: A double-blind, randomized, controlled clinical trial.
    Shahbazian H; Shayanpour S; Ghorbani A
    Saudi J Kidney Dis Transpl; 2016 Jan; 27(1):88-93. PubMed ID: 26787572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl cysteine for the conversion of atrial fibrillation into sinus rhythm after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled pilot study.
    Ozaydin M; Erdogan D; Yucel H; Peker O; Icli A; Akcay S; Etli M; Ceyhan BM; Sutcu R; Varol E; Dogan A; Yavuz T
    Int J Cardiol; 2013 May; 165(3):580-3. PubMed ID: 23041016
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
    Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
    J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
    Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
    Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine replenishes glutathione in HIV infection.
    De Rosa SC; Zaretsky MD; Dubs JG; Roederer M; Anderson M; Green A; Mitra D; Watanabe N; Nakamura H; Tjioe I; Deresinski SC; Moore WA; Ela SW; Parks D; Herzenberg LA; Herzenberg LA
    Eur J Clin Invest; 2000 Oct; 30(10):915-29. PubMed ID: 11029607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial.
    Moreno C; Langlet P; Hittelet A; Lasser L; Degré D; Evrard S; Colle I; Lemmers A; Devière J; Le Moine O
    J Hepatol; 2010 Dec; 53(6):1117-22. PubMed ID: 20801542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with Type 2 diabetes mellitus.
    Masha A; Brocato L; Dinatale S; Mascia C; Biasi F; Martina V
    J Endocrinol Invest; 2009 Apr; 32(4):352-6. PubMed ID: 19636205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. γ-Tocopherol-rich supplementation additively improves vascular endothelial function during smoking cessation.
    Mah E; Pei R; Guo Y; Ballard KD; Barker T; Rogers VE; Parker BA; Taylor AW; Traber MG; Volek JS; Bruno RS
    Free Radic Biol Med; 2013 Dec; 65():1291-1299. PubMed ID: 24075893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of N-acetylcysteine supplementation on oxidative stress status and alveolar inflammation in people exposed to asbestos: a double-blind, randomized clinical trial.
    Alfonso H; Franklin P; Ching S; Croft K; Burcham P; Olsen N; Reid A; Joyce D; de Klerk N; Musk AB
    Respirology; 2015 Oct; 20(7):1102-7. PubMed ID: 26172395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetylcysteine improves EEG measures of auditory deviance detection and neural synchronization in schizophrenia: A randomized, controlled pilot study.
    Yang YS; Davis MC; Wynn JK; Hellemann G; Green MF; Marder SR
    Schizophr Res; 2019 Jun; 208():479-480. PubMed ID: 30712814
    [No Abstract]   [Full Text] [Related]  

  • 20. Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension.
    Schneider MP; Delles C; Schmidt BM; Oehmer S; Schwarz TK; Schmieder RE; John S
    Am J Hypertens; 2005 Aug; 18(8):1111-7. PubMed ID: 16109326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.